Literature DB >> 28160943

Synthesis and in silico studies of novel sulfonamides having oxadiazole ring: As β-glucuronidase inhibitors.

Muhammad Taha1, Mohd Syukri Baharudin2, Nor Hadiani Ismail2, Manikandan Selvaraj3, Uzma Salar4, Khaled A A Alkadi5, Khalid Mohammed Khan4.   

Abstract

Novel sulfonamides having oxadiazole ring were synthesized by multistep reaction and evaluated to check in vitro β-glucuronidase inhibitory activity. Luckily, except compound 13, all compounds were found to demonstrate good inhibitory activity in the range of IC50=2.40±0.01-58.06±1.60μM when compared to the standard d-saccharic acid 1,4-lactone (IC50=48.4±1.25μM). Structure activity relationship was also presented. However, in order to ensure the SAR as well as the molecular interactions of compounds with the active site of enzyme, molecular docking studies on most active compounds 19, 16, 4 and 6 was carried out. All derivatives were fully characterized by 1H NMR, 13C NMR and EI-MS spectroscopic techniques. CHN analysis was also presented.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  In silico; In vitro; Oxadiazole; Sulfonamides; Synthesis; β-Glucuronidase inhibitory activity

Mesh:

Substances:

Year:  2017        PMID: 28160943     DOI: 10.1016/j.bioorg.2017.01.015

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  5 in total

Review 1.  Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.

Authors:  Paul Awolade; Nosipho Cele; Nagaraju Kerru; Lalitha Gummidi; Ebenezer Oluwakemi; Parvesh Singh
Journal:  Eur J Med Chem       Date:  2019-12-04       Impact factor: 6.514

2.  Bioinformatics: A rational combine approach used for the identification and in-vitro activity evaluation of potent β-Glucuronidase inhibitors.

Authors:  Maria Yousuf; Nimra Naveed Shaikh; Zaheer Ul-Haq; M Iqbal Choudhary
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

Review 3.  Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review.

Authors:  Chuang Zhao; K P Rakesh; L Ravidar; Wan-Yin Fang; Hua-Li Qin
Journal:  Eur J Med Chem       Date:  2018-11-22       Impact factor: 6.514

4.  Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study.

Authors:  Rafaqat Hussain; Shahid Iqbal; Mazloom Shah; Wajid Rehman; Shoaib Khan; Liaqat Rasheed; Fazal Rahim; Ayed A Dera; Sana Kehili; Eslam B Elkaeed; Nasser S Awwad; Majed A Bajaber; Mohammed Issa Alahmdi; Hamad Alrbyawi; Hashem O Alsaab
Journal:  Molecules       Date:  2022-09-30       Impact factor: 4.927

5.  Thiazolidin-2-cyanamides derivatives as novel potent Escherichia coli β-glucuronidase inhibitors and their structure-inhibitory activity relationships.

Authors:  Tao-Shun Zhou; Bin Wei; Min He; Ya-Sheng Li; Ya-Kun Wang; Si-Jia Wang; Jian-Wei Chen; Hua-Wei Zhang; Zi-Ning Cui; Hong Wang
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.